开云app官网登录入口网页版-官方正版

#复发/难治性大B细胞淋巴瘤#

0篇内容 | 485人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2226388, encodeId=e63f22263880a, content=<a href='/topic/show?id=a80f10e3046' target=_blank style='color:#2F92EE;'>#LBCL#</a> <a href='/topic/show?id=b633108840b8' target=_blank style='color:#2F92EE;'>#axi-cel#</a> <a href='/topic/show?id=206e112102dd' target=_blank style='color:#2F92EE;'>#复发/难治性大B细胞淋巴瘤#</a>, objectTitle=【JCO】axi-cel治疗LBCL 5年随访，29%的患者持续缓解, objectType=article, longId=843638, objectId=ff29843638e4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240905/1725521610942_8538692.jpg, objectUrl=/article/show_article.do?id=ff29843638e4, replyNumber=0, likeNumber=10, createdTime=15小时前, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ff29843638e4, moduleTitle=【JCO】axi-cel治疗LBCL 5年随访，29%的患者持续缓解, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ff29843638e4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2212994, encodeId=11dc2212994ff, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=a80f10e3046' target=_blank style='color:#2F92EE;'>#LBCL#</a> <a href='/topic/show?id=206e112102dd' target=_blank style='color:#2F92EE;'>#复发/难治性大B细胞淋巴瘤#</a>, objectTitle=【AJH】放疗作为R/R LBCL患者CAR-T治疗的桥接策略, objectType=article, longId=832649, objectId=bd5c8326493f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719571705502_5579292.jpg, objectUrl=/article/show_article.do?id=bd5c8326493f, replyNumber=0, likeNumber=116, createdTime=2024-07-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bd5c8326493f, moduleTitle=【AJH】放疗作为R/R LBCL患者CAR-T治疗的桥接策略, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bd5c8326493f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198818, encodeId=84b321988188a, content=<a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=206e112102dd' target=_blank style='color:#2F92EE;'>#复发/难治性大B细胞淋巴瘤#</a>, objectTitle=Haematologica：760例不同亚型LBCL接受CAR-T治疗的结局, objectType=article, longId=821691, objectId=861e82169128, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894916699_4754896.jpeg, objectUrl=/article/show_article.do?id=861e82169128, replyNumber=0, likeNumber=87, createdTime=2024-04-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=861e82169128, moduleTitle=Haematologica：760例不同亚型LBCL接受CAR-T治疗的结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=861e82169128)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2192283, encodeId=ca6e2192283df, content=<a href='/topic/show?id=15681121004f' target=_blank style='color:#2F92EE;'>#同种异体双阴性T细胞#</a> <a href='/topic/show?id=02c2112101af' target=_blank style='color:#2F92EE;'>#RJMty19#</a> <a href='/topic/show?id=206e112102dd' target=_blank style='color:#2F92EE;'>#复发/难治性大B细胞淋巴瘤#</a>, objectTitle=客观缓解率可达100%！《柳叶刀》子刊：新型现货型细胞疗法，具有强大抗肿瘤活性, objectType=article, longId=816510, objectId=86d88165107d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=86d88165107d, replyNumber=0, likeNumber=49, createdTime=2024-03-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=86d88165107d, moduleTitle=客观缓解率可达100%！《柳叶刀》子刊：新型现货型细胞疗法，具有强大抗肿瘤活性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=86d88165107d)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

同种异体双阴性T细胞 RJMty19 复发/难治性大B细胞淋巴瘤

2024-03-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#LBCL# #axi-cel# #复发/难治性大B细胞淋巴瘤#

【JCO】axi-cel治疗LBCL 5年随访，29%的患者持续缓解

15小时前发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#CAR-T# #LBCL# #复发/难治性大B细胞淋巴瘤#

【AJH】放疗作为R/R LBCL患者CAR-T治疗的桥接策略

2024-07-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#DLBCL# #CAR-T# #复发/难治性大B细胞淋巴瘤#

Haematologica：760例不同亚型LBCL接受CAR-T治疗的结局

2024-04-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#同种异体双阴性T细胞# #RJMty19# #复发/难治性大B细胞淋巴瘤#

客观缓解率可达100%！《柳叶刀》子刊：新型现货型细胞疗法，具有强大抗肿瘤活性

2024-03-09发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务